Table 7.
Second primary malignancies (SPMs)
| SPM | n (%) | Time to enrollment (months) | sVRD (courses) | Prior therapies |
|---|---|---|---|---|
| Acute lymphoblastic leukemia | 1 (6.3) | 38 | 18 | VAD, ASCT |
| Myelodysplastic syndrome | 1 (6.3) | 60 | 7 | VAD, Bd |
VAD vincristine, adriamycin and dexamethasone, ASCT autologous hematopoietic stem cell transplantation, Bd bortezomib plus dexamethasone